Phase II Clinical Trial of Bevacizumab and Low-Dose Metronomic Oral Cyclophosphamide in Recurrent Ovarian Cancer: A Trial of the California, Chicago, and Princess Margaret Hospital Phase II Consortia

Agustin A. Garcia, Hal Hirte, Gini Fleming, Dongyun Yang, Denice D. Tsao-Wei, Lynda Roman, Susan Groshen, Steve Swenson, Frank Markland, David R Gandara, Sidney A Scudder, Robert Morgan, Helen Chen, Heinz Josef Lenz, Amit M. Oza

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Phase II Clinical Trial of Bevacizumab and Low-Dose Metronomic Oral Cyclophosphamide in Recurrent Ovarian Cancer: A Trial of the California, Chicago, and Princess Margaret Hospital Phase II Consortia'. Together they form a unique fingerprint.

Medicine & Life Sciences